GlaxoSmithKline's experimental once-daily lung drug LAMA/LABA showed positive results on Monday from late stage trials in patients with chronic obstructive pulmonary disease (COPD)
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment